Peptidoglycan enhances secretion of monocyte chemoattractants via multiple signaling pathways

Biochemical and Biophysical Research Communications

Volumn 408, Issue 1, 2011, Pages 132-138

  Lee, Sae A ^a   Kim, Sun Mi ^a   Son, Yong Hae ^a   Lee, Chung Won ^b   Chung, Sung Woon ^a   Eo, Seong Kug ^c   Rhim, Byung Yong ^a   Kim, Koanhoi ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Atherosclerosis; Chemokine; Monocytes macrophages; Peptidoglycan

Indexed keywords

BETA CHEMOKINE; CHEMOATTRACTANT; CHEMOKINE RECEPTOR CCR2; CUTANEOUS T CELL ATTRACTING CHEMOKINE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLCHOLINE; PROTEIN KINASE B; PROTEIN KINASE C; TOLL LIKE RECEPTOR 2;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MONOCYTIC LEUKEMIA; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULITIS;

CELL LINE, TUMOR; CHEMOKINE CCL2; CHEMOKINE CCL4; CHEMOTACTIC FACTORS; HUMANS; MONOCYTES; PEPTIDOGLYCAN; PHOSPHOLIPID ETHERS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 79955368086     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.136     Document Type: Article

References (25)

1. Aukrust P., Halvorsen B., Yndestad A., Ueland T., Oie E., Otterdal K., Gullestad L., Damas J.K. Chemokines and cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1909-1919.
2. Pawlak K., Pawlak D., Brzosko S., Mysliwiec M. Carotid atherosclerosis is associated with enhanced beta-chemokine levels in patients on continuous ambulatory peritoneal dialysis. Atherosclerosis 2006, 186:146-151.
3. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1). J. Interferon Cytokine Res. 2009, 29:313-326.
4. Takeya M., Yoshimura T., Leonard E.J., Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol. 1993, 24:534-539.
5. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., Rollins B.J., Charo I.F. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 1999, 103:773-778.
6. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 1999, 163:1-5.
7. Nijhuis M.M., Pasterkamp G., Sluis N.I., de Kleijn D.P., Laman J.D., Ulfman L.H. Peptidoglycan increases firm adhesion of monocytes under flow conditions and primes monocyte chemotaxis. J. Vasc. Res. 2007, 44:214-222.
8. Dobrina A., Nardon E., Vecile E., Cinco M., Patriarca P. Leptospira icterohemorrhagiae and leptospire peptidolgycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes. Infect. Immun. 1995, 63:2995-2999.
9. Langer M., Malykhin A., Maeda K., Chakrabarty K., Williamson K.S., Feasley C.L., West C.M., Metcalf J.P., Coggeshall K.M. Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-activated protein kinase pathway. PLoS One 2008, 3:e3706.
10. Wang Z.M., Liu C., Dziarski R. Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J. Biol. Chem. 2000, 275:20260-20267.
11. Laman J.D., Schoneveld A.H., Moll F.L., van Meurs M., Pasterkamp G. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am. J. Cardiol. 2002, 90:119-123.
12. Choi K.H., Park J.W., Kim H.Y., Kim Y.H., Kim S.M., Son Y.H., Park Y.C., Eo S.K., Kim K. Cellular factors involved in CXCL8 expression induced by glycated serum albumin in vascular smooth muscle cells. Atherosclerosis 2010, 209:58-65.
13. Itoh H., Yamamura S., Ware J.A., Zhuang S., Mii S., Liu B., Kent K.C. Differential effects of protein kinase C on human vascular smooth muscle cell proliferation and migration. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H359-H370.
14. Song M., Phelps D.S. Comparison of SP-A and LPS effects on the THP-1 monocytic cell line. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L110-L117.
15. Hahn-Windgassen A., Nogueira V., Chen C.C., Skeen J.E., Sonenberg N., Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 2005, 280:32081-32089.
16. Cardoso L.S., Araujo M.I., Goes A.M., Pacifico L.G., Oliveira R.R., Oliveira S.C. Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb. Cell Fact. 2007, 6:1.
17. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2002, 2:489-501.
18. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
19. Shaw R.J., Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006, 441:424-430.
20. Thobe B.M., Frink M., Hildebrand F., Schwacha M.G., Hubbard W.J., Choudhry M.A., Chaudry I.H. The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage. J. Cell. Physiol. 2007, 210:667-675.
21. Saetre T., Kahler H., Foster S.J., Lyberg T. Peptidoglycan and lipoteichoic acid, components of the streptococcal cell wall, have marked and differential effects on adhesion molecule expression and the production of reactive oxygen species in human whole blood leukocytes. Scand. J. Clin. Lab. Invest. 2000, 60:311-321.
22. Miesel R., Sanocka D., Kurpisz M., Kroger H. Antiinflammatory effects of NADPH oxidase inhibitors. Inflammation 1995, 19:347-362.
23. Tzeng J.I., Chen B.C., Chang H.M., Wang J.J., Sureshbabu M., Chien M.H., Hsu M.J., Bien M.Y., Chiu W.T., Hong C.Y., Lin C.H. Involvement of phosphatidylcholine-phospholipase C and protein kinase C in peptidoglycan-induced nuclear factor-kappaB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages. Pharmacol. Res. 2010, 61:162-166.
24. Asehnoune K., Strassheim D., Mitra S., Yeol Kim J., Abraham E. Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB. Cell Signal. 2005, 17:385-394.
25. 2+ entry in DDT1 MF-2 cells. Br. J. Pharmacol. 1996, 119:730-736.